%0 Journal Article
%A Gonzalez-Cantero, Alvaro
%A Teklu, Meron
%A Sorokin, Alexander V
%A Prussick, Ronald
%A González-Cantero, Jorge
%A Martin-Rodriguez, Jose Luis
%A Patel, Nidhi
%A Parel, Philip M
%A Manyak, Grigory A
%A Teague, Heather L
%A Rodante, Justin A
%A Keel, Andrew
%A Pérez-Hortet, Cristina
%A Sanchéz-Moya, Ana I
%A Jiménez, Natalia
%A Ballester, Asunción
%A Solis, Jorge
%A Fernandez-Friera, Leticia
%A Barderas, María G
%A Gonzalez-Calvin, Jorge L
%A Jaen, Pedro
%A Playford, Martin P
%A Dey, Amit K
%A Gelfand, Joel M
%A Mehta, Nehal N
%T Subclinical Liver Disease Is Associated with Subclinical Atherosclerosis in Psoriasis: Results from Two Observational Studies.
%D 2021
%U http://hdl.handle.net/10668/22319
%X Psoriasis is associated with a higher risk of liver diseases. We investigated the impact of hepatic steatosis (European cohort) and hepatic inflammation (United States cohort) on subclinical atherosclerosis. In the European cohort (n = 76 psoriasis participants and 76 controls), nonalcoholic fatty liver disease, assessed by the sonographic hepatorenal index, was more prevalent in psoriasis than in controls (61% vs. 45%; P = 0.04). Participants with psoriasis with nonalcoholic fatty liver disease had a higher prevalence of subclinical atherosclerosis (ultrasonographic presence of plaque in femoral or carotid arteries) than participants with psoriasis without nonalcoholic fatty liver disease (61% vs. 23%; P = 0.006) and controls with nonalcoholic fatty liver disease (61% vs. 32%; P
%~